Viatris Share Holder Equity 2010-2024 | VTRS

Viatris share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • Viatris share holder equity for the quarter ending June 30, 2024 was $19.520B, a 6.35% decline year-over-year.
  • Viatris share holder equity for 2023 was $20.467B, a 2.87% decline from 2022.
  • Viatris share holder equity for 2022 was $21.072B, a 2.83% increase from 2021.
  • Viatris share holder equity for 2021 was $20.493B, a 10.72% decline from 2020.
Viatris Annual Share Holder Equity
(Millions of US $)
2023 $20,467
2022 $21,072
2021 $20,493
2020 $22,954
2019 $11,884
2018 $12,167
2017 $13,308
2016 $11,118
2015 $9,766
2014 $3,276
2013 $2,960
2012 $3,356
2011 $3,505
2010 $3,615
2009 $3,145
Viatris Quarterly Share Holder Equity
(Millions of US $)
2024-06-30 $19,520
2024-03-31 $20,014
2023-12-31 $20,467
2023-09-30 $20,866
2023-06-30 $20,843
2023-03-31 $20,928
2022-12-31 $21,072
2022-09-30 $19,182
2022-06-30 $19,805
2022-03-31 $20,448
2021-12-31 $20,493
2021-09-30 $21,141
2021-06-30 $21,207
2021-03-31 $21,415
2020-12-31 $22,954
2020-09-30 $12,548
2020-06-30 $11,746
2020-03-31 $11,263
2019-12-31 $11,884
2019-09-30 $11,463
2019-06-30 $11,903
2019-03-31 $11,892
2018-12-31 $12,167
2018-09-30 $12,066
2018-06-30 $12,209
2018-03-31 $13,177
2017-12-31 $13,308
2017-09-30 $13,292
2017-06-30 $12,833
2017-03-31 $11,656
2016-12-31 $11,118
2016-09-30 $11,829
2016-06-30 $10,331
2016-03-31 $10,275
2015-12-31 $9,766
2015-09-30 $9,815
2015-06-30 $9,569
2015-03-31 $9,093
2014-12-31 $3,276
2014-09-30 $3,406
2014-06-30 $3,353
2014-03-31 $3,192
2013-12-31 $2,960
2013-09-30 $3,233
2013-06-30 $2,945
2013-03-31 $2,887
2012-12-31 $3,356
2012-09-30 $3,624
2012-06-30 $3,199
2012-03-31 $3,779
2011-12-31 $3,505
2011-09-30 $3,494
2011-06-30 $3,881
2011-03-31 $3,917
2010-12-31 $3,615
2010-09-30 $3,543
2010-06-30 $2,979
2010-03-31 $3,178
2009-12-31 $3,145
2009-09-30 $3,072
2009-06-30 $2,912
2009-03-31 $2,649
Sector Industry Market Cap Revenue
Medical Medical Services $13.858B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00